BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ducarmon QR, Kuijper EJ, Olle B. Opportunities and Challenges in Development of Live Biotherapeutic Products to Fight Infections. J Infect Dis 2021;223:S283-9. [PMID: 33576793 DOI: 10.1093/infdis/jiaa779] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Manheim D, Wiȩcek W, Schmit V, Morrison J; 1Day Sooner Research Team. Exploring Risks of Human Challenge Trials For COVID-19. Risk Anal 2021;41:710-20. [PMID: 33942351 DOI: 10.1111/risa.13726] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Coleman ME, Dietert RR, North DW, Stephenson MM. Enhancing Human Superorganism Ecosystem Resilience by Holistically ‘Managing Our Microbes’. Applied Microbiology 2021;1:471-97. [DOI: 10.3390/applmicrobiol1030031] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
3 [DOI: 10.1101/2020.11.19.20234658] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Ranallo RT, McDonald LC, Halpin AL, Hiltke T, Young VB. The State of Microbiome Science at the Intersection of Infectious Diseases and Antimicrobial Resistance. J Infect Dis 2021;223:S187-93. [PMID: 33667294 DOI: 10.1093/infdis/jiab020] [Reference Citation Analysis]